Curcumin, the active ingredient in turmeric, has been shown to induce programmed cell death (apoptosis) in cancer cells, making it a promising treatment option for individuals with cancer. Research has demonstrated that curcumin can selectively target cancer cells while leaving healthy cells unharmed, making it an attractive alternative to traditional cancer treatments that can damage healthy tissue. Curcumin has been shown to induce apoptosis in a variety of cancers, including breast, prostate, colon, and lung cancer, by interfering with multiple cellular signaling pathways involved in cancer development and progression. Additionally, curcumin IV has been shown to enhance the effectiveness of chemotherapy and radiation therapy, making it a promising adjunct therapy for individuals with cancer. Overall, curcumin is a powerful tool in the fight against cancer.